Articles > coronavirus

Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!

Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!

Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!

Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

COVID-19 has completely changed the way Americans live, work, and play. The pandemic has sent over 100 million people home to work in a safe, socially-distanced way. Flexible work schedules could afford us time and space to make thoughtful management decisions for our diabetes.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

Important preliminary findings from the T1D Exchange multi-center surveillance study on people with T1D and COVID-19 were published this week in the Diabetes Care journal.

Preliminary results of our population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” were recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association. The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.